Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Cells|July 26, 2024
Targeting DNA Methylation Machinery in Pediatric Solid TumorsCamilla Cristalli, Katia ScotlandiPolymers|October 14, 2022
A 3D Collagen-Based Bioprinted Model to Study Osteosarcoma Invasiveness and Drug ResponseEvelin Pellegrini, Giovanna Desando, Mauro Petretta, et al.International Journal of Molecular Sciences|February 10, 2024
CD99 Modulates the Proteomic Landscape of Ewing Sarcoma Cells and Related Extracellular VesiclesAlessandra De Feo, Marcello Manfredi, Caterina Mancarella, et al.Journal of Experimental & Clinical Cancer Research : CR|December 28, 2019
ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activityCinzia Zucchini, Maria Cristina Manara, Camilla Cristalli, et al.Frontiers in Endocrinology|June 17, 2022
Novel Targeting of DNA Methyltransferase Activity Inhibits Ewing Sarcoma Cell Proliferation and Enhances Tumor Cell Sensitivity to DNA Damaging Drugs by Activating the DNA Damage ResponseCamilla Cristalli, Maria Cristina Manara, Sergio Valente, et al.Cancer Immunology Research|December 5, 2023
Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and MacrophagesMaria Cristina Manara, Cristina Manferdini, Camilla Cristalli, et al.Molecular Cancer Therapeutics|July 1, 2018
A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma TherapyMaria Cristina Manara, Sergio Valente, Camilla Cristalli, et al.Nature Communications|December 4, 2021
Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcomaGeorgia Zoumpoulidou, Carlos Alvarez-Mendoza, Caterina Mancusi, et al.Cellular Oncology (Dordrecht, Netherlands)|September 23, 2022
ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axisMichela Pasello, Anna Maria Giudice, Camilla Cristalli, et al.Scientific Reports|August 23, 2019
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigationsPatrizia Nanni, Lorena Landuzzi, Maria Cristina Manara, et al.Pageof 2